Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 3
2011 4
2013 2
2014 1
2016 2
2017 2
2019 1
2021 1
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
The myotonic dystrophy type 1 drug development pipeline: 2022 edition.
Pascual-Gilabert M, Artero R, López-Castel A. Pascual-Gilabert M, et al. Among authors: lopez castel a. Drug Discov Today. 2023 Mar;28(3):103489. doi: 10.1016/j.drudis.2023.103489. Epub 2023 Jan 9. Drug Discov Today. 2023. PMID: 36634841 Free article. Review.
Antagonistic roles of canonical and Alternative-RPA in disease-associated tandem CAG repeat instability.
Gall-Duncan T, Luo J, Jurkovic CM, Fischer LA, Fujita K, Deshmukh AL, Harding RJ, Tran S, Mehkary M, Li V, Leib DE, Chen R, Tanaka H, Mason AG, Lévesque D, Khan M, Razzaghi M, Prasolava T, Lanni S, Sato N, Caron MC, Panigrahi GB, Wang P, Lau R, Castel AL, Masson JY, Tippett L, Turner C, Spies M, La Spada AR, Campos EI, Curtis MA, Boisvert FM, Faull RLM, Davidson BL, Nakamori M, Okazawa H, Wold MS, Pearson CE. Gall-Duncan T, et al. Among authors: castel al. Cell. 2023 Oct 26;186(22):4898-4919.e25. doi: 10.1016/j.cell.2023.09.008. Epub 2023 Oct 11. Cell. 2023. PMID: 37827155
Myotonic dystrophy type 1 drug development: A pipeline toward the market.
Pascual-Gilabert M, López-Castel A, Artero R. Pascual-Gilabert M, et al. Among authors: lopez castel a. Drug Discov Today. 2021 Jul;26(7):1765-1772. doi: 10.1016/j.drudis.2021.03.024. Epub 2021 Mar 31. Drug Discov Today. 2021. PMID: 33798646 Free PMC article. Review.
In vivo strategies for drug discovery in myotonic dystrophy disorders.
Garcia-Alcover I, López Castel A, Perez-Alonso M, Artero R. Garcia-Alcover I, et al. Among authors: lopez castel a. Drug Discov Today Technol. 2013 Spring;10(1):e97-102. doi: 10.1016/j.ddtec.2012.02.001. Drug Discov Today Technol. 2013. PMID: 24050236 Review.
Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers.
Fernandez-Costa JM, Llamusi B, Bargiela A, Zulaica M, Alvarez-Abril MC, Perez-Alonso M, Lopez de Munain A, Lopez-Castel A, Artero R. Fernandez-Costa JM, et al. Among authors: lopez castel a. PLoS One. 2016 Feb 26;11(2):e0150501. doi: 10.1371/journal.pone.0150501. eCollection 2016. PLoS One. 2016. PMID: 26919350 Free PMC article.
20 results